Cargando…
Lung Cancer Organoids as Avatars of Patients With Lung Cancer in the Prediction of Therapeutic Response
Autores principales: | Rosell, Rafael, Pedraz-Valdunciel, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568265/ https://www.ncbi.nlm.nih.gov/pubmed/37842325 http://dx.doi.org/10.1016/j.jtocrr.2023.100571 |
Ejemplares similares
-
Osimertinib and pterostilbene in EGFR-mutation-positive non-small cell lung cancer (NSCLC)
por: Bracht, Jillian Wilhelmina Paulina, et al.
Publicado: (2019) -
Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities
por: Rosell, Rafael, et al.
Publicado: (2021) -
Urological cancer organoids, patients' avatars for precision medicine: past, present and future
por: Chen, Haotian, et al.
Publicado: (2022) -
Patient-derived organoids as personalized avatars and a potential immunotherapy model in cervical cancer
por: Huang, Hua, et al.
Publicado: (2023) -
Science and biology drives the immune system to cure lung cancer patients: a revolution but not without challenges
por: Karachaliou, Niki, et al.
Publicado: (2018)